HARRISBURG — A series of Spotlight PA investigations has revealed weak oversight of doctors in Pennsylvania’s medical marijuana program, prompted efforts to change state law, and led to greater transparency from the state health department.
The findings have also raised questions from experts, including fellow medical marijuana doctors, about the quality of care many patients receive when they seek a medical marijuana card.
Records obtained through legal victories bolstered Spotlight PA’s investigations. A first-of-its-kind analysis revealed how anxiety disorders came to dominate the big business of medical marijuana cards in Pennsylvania, despite limited evidence of the drug’s effectiveness and concerns about its potential to worsen anxiety symptoms.